ANVIGLOBE Trademark

Trademark Overview


On Thursday, June 9, 2022, a trademark application was filed for ANVIGLOBE with the United States Patent and Trademark Office. The USPTO has given the ANVIGLOBE trademark a serial number of 79346023. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by CELLTRION, INC.. The ANVIGLOBE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of COVID-19, pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for the treatment of respiratory diseases, pharmaceutical preparations for the treatment of auto-immune diseases, pharmaceutical preparations for the treatment of immune diseases, pharmaceutical preparations for the treatment of inflammatory diseases, pharmaceutical preparations for use in dermatological diseases, pharmaceutical preparations for the treatment of psoriasis, pharmaceutical preparations for the treatment of arthritis, pharmaceutical preparations for the treatment of spondylitis, pharmaceutical preparations for the treatment of Multiple Sclerosis, pharmaceutical preparations for the treatment of cancer and tumor, pharmaceutical preparations for the treatment of digestive diseases, pharmaceutical preparations for the treatment of metabolic diseases, pharmaceutical preparations for the tre...
anviglobe

General Information


Serial Number79346023
Word MarkANVIGLOBE
Filing DateThursday, June 9, 2022
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7256687
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of COVID-19, pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for the treatment of respiratory diseases, pharmaceutical preparations for the treatment of auto-immune diseases, pharmaceutical preparations for the treatment of immune diseases, pharmaceutical preparations for the treatment of inflammatory diseases, pharmaceutical preparations for use in dermatological diseases, pharmaceutical preparations for the treatment of psoriasis, pharmaceutical preparations for the treatment of arthritis, pharmaceutical preparations for the treatment of spondylitis, pharmaceutical preparations for the treatment of Multiple Sclerosis, pharmaceutical preparations for the treatment of cancer and tumor, pharmaceutical preparations for the treatment of digestive diseases, pharmaceutical preparations for the treatment of metabolic diseases, pharmaceutical preparations for the treatment of endocrine diseases, pharmaceutical preparations for the treatment of genitourinary diseases, pharmaceutical preparations for the treatment of hepatological diseases, pharmaceutical preparations for the treatment of eye diseases, pharmaceutical preparations for the treatment of musculoskeletal disorders, pharmaceutical preparations for the treatment of genetic disorders, pharmaceutical preparations for the treatment of neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 9, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Monday, October 16, 2023NOTIFICATION PROCESSED BY IB
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 31, 2023REFUSAL PROCESSED BY IB
Friday, May 5, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 5, 2023REFUSAL PROCESSED BY MPU
Friday, March 17, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 16, 2023NON-FINAL ACTION WRITTEN
Monday, March 13, 2023ASSIGNED TO EXAMINER
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 2, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB